Insider Selling: Hims & Hers Health (NYSE:HIMS) CFO Sells 9,067 Shares of Stock
Hims & Hers Health, Inc. (NYSE:HIMS - Get Free Report) CFO Oluyemi Okupe sold 9,067 shares of the companys stock…
28,878$
-5,22%
Echtzeit-Aktienkurs Hims & Hers Health
Bid:
Ask:
Nachrichten zur Hims & Hers Health Aktie
Hims & Hers Health (NYSE:HIMS) Stock Price Down 6.2%
Hims & Hers Health (NYSE:HIMS) Trading Down 6.2% - Whats Next?…
Hims & Hers Health (NYSE:HIMS) Downgraded to "Strong Sell" Rating by Zacks Research
Zacks Research cut Hims & Hers Health from a "hold" rating to a "strong sell" rating in a research report…
Hims And Hers Wegovy Talks Could Reshape Growth And Subscriber Economics
Hims & Hers Health (NYSE:HIMS) is in discussions with Novo Nordisk to add Wegovy injections to its telehealth platform.The talks…
Why Hims & Hers Health (HIMS) Stock Is Down Today
What Happened? Shares of telehealth company Hims & Hers Health NYSE:HIMS fell 2.2% in the morning session after Morgan Stanley…
Why Hims & Hers Health (HIMS) Stock Is Down Today
Shares of telehealth company Hims & Hers Health (NYSE:HIMS) fell 2.2% in the morning session after Morgan Stanley reiterated its…
Hims & Hers: Lofty Valuation Persists Amid Market Caution
Hims & Hers US4330001060…
Why Hims & Hers Health (HIMS) Stock Is Down Today
Stock screener for investors and traders, financial visualizations.…
Morgan Stanley maintains Equalweight rating on Hims and Hers stock By Investing.com
Morgan Stanley maintains Equalweight rating on Hims and Hers stock…
Morgan Stanley maintains Equalweight rating on Hims and Hers stock By Investing.com
Morgan Stanley maintains Equalweight rating on Hims and Hers stock…
Why Shares of Hims & Hers Health (HIMS) Are Falling Today
Recent DevelopmentsHims & Hers Health (NYSE:HIMS), a telehealth provider, saw its stock dip by 2.2% during morning trading after Morgan…
Hims & Hers Expands Platform-Led Access to Digital Healthcare
The renowned health and wellness platform, Hims & Hers Health, Inc. HIMS, built its growth strategy around a highly scalable,…
Hims & Hers: The High-Stakes Balancing Act of Growth and Profitability
Hims & Hers US4330001060…
Hims & Hers And HIMZ: Short?Term Pain From Novo, Long?Term Opportunity Still Bright
Hims & Hers Health, Inc. faces short-term pressure after missing Novo’s partner list, but lab testing boosts long-term growth. Click…
Is Most-Watched Stock Hims & Hers Health, Inc. (HIMS) Worth Betting on Now?
Zacks.com users have recently been watching Hims & Hers Health (HIMS) quite a bit. Thus, it is worth knowing the…
Is Hims & Hers (HIMS) Using Zava to Balance GLP-1 Uncertainty with Broader Platform Ambitions?
In recent months, Hims & Hers Health has pushed beyond its original focus areas, expanding into diagnostics, hormone health, and…
Hims & Hers Stock Faces Scrutiny Over Compounded GLP-1 Dependencies
Hims & Hers US4330001060…
BofA Maintains an Underperform Rating on Hims & Hers Health, Inc. (HIMS)
TheFly reported on January 8, 2026, that BofA reduced the price target for Hims & Hers Health, Inc. (NYSE:HIMS) to…
BofA Maintains an Underperform Rating on Hims & Hers Health, Inc. (HIMS)
Hims & Hers Health, Inc. (NYSE:HIMS) is among the 7 Best Beauty Stocks to Buy Right Now. TheFly reported on…
Hims & Hers Expands Weight Loss Program and Launches Hers Platform in the UK
Hims & Hers has expanded its presence in the UK by introducing its comprehensive weight loss program, alongside the official…
BofA Maintains an Underperform Rating on Hims & Hers Health, Inc. (HIMS)
Stock screener for investors and traders, financial visualizations.…
Hims & Hers: Growth Catalysts Or Margin Trap
Hims & Hers was rated Hold amid margin pressure, Amazon-driven competition, & uncertain catalysts. Learn more about HIMS stock.…
A Look At Hims & Hers Health (HIMS) Valuation As Amazon Targets The Weight Loss Segment
Hims & Hers Health (HIMS) is back in focus after Amazon Pharmacy said it will offer Novo Nordisk’s Wegovy weight…
Why Hims & Hers Health (HIMS) Is Down 6.8% After Amazon Pharmacy Adds Wegovy Weight-Loss Pill
In recent days, Amazon Pharmacy announced it would begin offering Novo Nordisk’s Wegovy once-daily weight-loss pill through both insurance and…
Is It Too Late To Consider Hims & Hers Health (HIMS) After Its 4x Three-Year Surge?
This article examines what the current share price of Hims & Hers Health may be implying about the company, and…
Why Hims & Hers Health, Inc. (HIMS) Outpaced the Stock Market Today
In the most recent trading session, Hims & Hers Health, Inc. (HIMS) closed at $32.34, indicating a +2.05% shift from…
Why Hims & Hers Health, Inc. (HIMS) Outpaced the Stock Market Today
In the most recent trading session, Hims & Hers Health, Inc. (HIMS) closed at $32.34, indicating a +2.05% shift from…
Hims & Hers Expands Platform-Led Access to Provider-Directed Care
Detailed price information for Hims & Hers Health Inc (HIMS-N) from The Globe and Mail including charting and trades.…
Hims & Hers stock is crashing: will it rebound soon?
Hims & Hers stock has nosedived in the past few months. It has dived by over 56% from its highest…
Hims & Hers stock is crashing: will it rebound soon?
Hims & Hers stock has nosedived in the past few months. It has dived by over 56% from its highest…
Evercore ISI Initiates Coverage on Hims (HIMS) with In-Line Rating
Key Takeaways Evercore ISI Group initiates coverage on Hims & Hers Health (HIMS) with an In-Line rating. Current…
Evercore ISI initiates Hims and Hers stock coverage with In Line rating By Investing.com
Evercore ISI initiates Hims and Hers stock coverage with In Line rating…
Evercore ISI initiates Hims and Hers stock coverage with In Line rating By Investing.com
Evercore ISI initiates Hims and Hers stock coverage with In Line rating…
Hims & Hers Health (HIMS) Receives Sell Rating Amid Overvaluation Concerns
Key Takeaways: Hims & Hers Health, Inc. (HIMS) faces valuation concerns with an elevated EV/EBIT ratio of…
Hims & Hers Health (HIMS) stock slides premarket after Amazon’s Wegovy pill move — what traders watch next
Hims & Hers Health (HIMS) stock slides premarket after Amazon’s Wegovy pill move — what traders watch next - TechStock²…
Is It Too Late To Consider Hims & Hers Health (HIMS) After Recent Share Price Pullback
For investors wondering whether Hims & Hers Health still offers good value after its rise as a telehealth brand, or…
A Look At Hims & Hers Health (HIMS) Valuation As Telehealth And Recurring Care Draw Fresh Attention
Hims & Hers Health (HIMS) is back in focus as investors reassess its telehealth model, weighing GLP-1 related interest and…
Hims & Hers Health Inc. Stock (HIMS) Opinions on Recent Price Target Cut
Recent Stock Decline: Hims & Hers Health Inc. has seen its stock price drop recently, with a notable decline of…
Hims & Hers stock slides as Amazon adds Wegovy pill, raising fresh pricing fears
Hims & Hers stock slides as Amazon adds Wegovy pill, raising fresh pricing fears - TechStock²…
Hims & Hers stock slides as Amazon starts selling Novo Nordisk’s new Wegovy pill
Hims & Hers stock slides as Amazon starts selling Novo Nordisk’s new Wegovy pill - TechStock²…
Hims & Hers Health: Capitalizing On Healthcare Innovation
…
Hims & Hers Health stock falls after Amazon Pharmacy adds Wegovy pill By Investing.com
Hims & Hers Health stock falls after Amazon Pharmacy adds Wegovy pill…
Hims & Hers CEO Bets On Personalized Healthcare And AI In 2026 — Wall Street Braces For A Costly Year
The development follows OpenAI’s rollout of ChatGPT Health, which helps users blend health information with AI-driven insights.…
Hims & Hers Growth Story Has A Lot To Prove In 2026
Hims & Hers stock is down 50% from all-time highs amid fading momentum in compounded GLP-1 offerings. Click here to…
Why Hims & Hers Health Stock Is Sliding Now
Hims & Hers Health ( ($HIMS) ) is experiencing volatility. Read on for a possible explanation for the stock’s unusual…
Hims & Hers Plunges 39.2% in 3 Months: Time to Hold the Stock or Sell?
Detailed price information for Hims & Hers Health Inc (HIMS-N) from The Globe and Mail including charting and trades.…
Hims & Hers Plunges 39.2% in 3 Months: Time to Hold the Stock or Sell?
Hims & Hers Health, Inc.’s HIMS investors have been experiencing some short-term losses lately. The San Francisco, CA-based health and…
Hims & Hers: Looking Beyond GLP-1s To The Next Phase Of Global Growth
Hims & Hers Health is significantly undervalued, with the market underestimating its growth potential and international expansion opportunities. Learn more…
2026: The Year of the Consumer in Healthcare
2026 is the year of the individual in healthcare, and we’ve built Hims & Hers to be the leader in…
Hims & Hers Health: Under-Appreciated Upside
…